Aerie Pharmaceuticals (Aerie Pharmaceuticals) Revenue per Share : $4.54 (TTM As of Sep. 2022)

Aerie Pharmaceuticals Revenue per Share Chart

Aerie Pharmaceuticals Annual Data
	Trend	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21
Revenue per Share		Get a 7-Day Free Trial					-	0.58	1.54	1.81	4.19

Aerie Pharmaceuticals Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Revenue per Share	Get a 7-Day Free Trial															0.63	2.46	0.63	0.70	0.76

Competitive Comparison of Aerie Pharmaceuticals's Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Aerie Pharmaceuticals's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aerie Pharmaceuticals's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aerie Pharmaceuticals's PS Ratio distribution charts can be found below:

* The bar in red indicates where Aerie Pharmaceuticals's PS Ratio falls into.

Aerie Pharmaceuticals Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Aerie Pharmaceuticals's Revenue Per Share for the fiscal year that ended in Dec. 2021 is calculated as

Aerie Pharmaceuticals's Revenue Per Share for the quarter that ended in Sep. 2022 is calculated as

Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aerie Pharmaceuticals  (NAS:AERI) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Aerie Pharmaceuticals Revenue per Share Related Terms

Thank you for viewing the detailed overview of Aerie Pharmaceuticals's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Aerie Pharmaceuticals (Aerie Pharmaceuticals) Business Description